{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-08T12:27:22.819968+00:00",
  "news": [
    {
      "title": "Amgen dances with Disco in $618M cancer target pact - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNWU1uUGRZSGdPc3pXNTRlZlltUndFQ1JRdnZNYWozbS12RWYxa3RCa0taQ3NJUVZhMGhKa09zOWJpY1N6OENMSGt5VUJEUUxhSmM4R0lQQjNKOGRudy1kM2tKUGQ5Tzc0MHBCQmJzX3IwWTI0eEFLUTY2RWIxZ3hnQVQ1djVmSzg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxNWU1uUGRZSGdPc3pXNTRlZlltUndFQ1JRdnZNYWozbS12RWYxa3RCa0taQ3NJUVZhMGhKa09zOWJpY1N6OENMSGt5VUJEUUxhSmM4R0lQQjNKOGRudy1kM2tKUGQ5Tzc0MHBCQmJzX3IwWTI0eEFLUTY2RWIxZ3hnQVQ1djVmSzg?oc=5\" target=\"_blank\">Amgen dances with Disco in $618M cancer target pact</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2026-01-07T15:15:45+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen Makes up to $840M Cancer Play With Dark Blue Takeover - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQY3dFOThfeGJqTnJrdXh5ZnU4NEZNWnNIalQxVTdEUnF3LWV5a3lDMUl2ZjY5Y1dVQ3QxdjRNaVVkRGhFZGNfRWpjc0ZHbWZnT2R6MjRzb0ROdnlqY05sanRnSkdfV3Vjb1FTZ3RONnBIUVdFUTdmeWhSZzhNZWl0bTRxZk1MYVB6dmpYWFZ4MG9JQkhodkpv?oc=5",
      "summary": "<ol><li><a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxQY3dFOThfeGJqTnJrdXh5ZnU4NEZNWnNIalQxVTdEUnF3LWV5a3lDMUl2ZjY5Y1dVQ3QxdjRNaVVkRGhFZGNfRWpjc0ZHbWZnT2R6MjRzb0ROdnlqY05sanRnSkdfV3Vjb1FTZ3RONnBIUVdFUTdmeWhSZzhNZWl0bTRxZk1MYVB6dmpYWFZ4MG9JQkhodkpv?oc=5\" target=\"_blank\">Amgen Makes up to $840M Cancer Play With Dark Blue Takeover</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font></li><li><a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5\" target=\"_blank\">AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font></li><li><a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxOa044Y293MWYzbUxtYmNwNkpnM1NKQUJYcTVBZjBYb01vZnJRdDdiNXhvR1dkWDhmTERoMlFjVUYzUzgwbzBRcUtUTVhBbFp1dFJLRjFSQ3N3WW5RUllCYTY4aWlIb2NvODB2RHgwVkVlLV9zbWhXRU0xS3B1U2V5Ng?oc=5\" target=\"_blank\">Amgen buys a novel leukaemia target | ApexOnco - Clinical Trials news and analysis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Oncology Pipeline</font></li></ol>",
      "published": "2026-01-07T13:06:32+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Amgen upgraded to buy at UBS on potential of MariTide, olpasiran - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPbjNGUllkZHAya0tLZUJSQ3pzSXc1YVo5dTNSczNCRWhweHZ6YTh3ZFVFYWdJbDk1NWkxNFROMjE1M1ItdV9RdVViM1BCdW5HaTFMRkhzQ2xTMnJnR0NpMTRsdjlZUW5HX1FCSEtqVkdHRE8xOFNHb2JvNFloWkRjeGJNeWpHb0oxTkdEaXZXNUVsQnM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxPbjNGUllkZHAya0tLZUJSQ3pzSXc1YVo5dTNSczNCRWhweHZ6YTh3ZFVFYWdJbDk1NWkxNFROMjE1M1ItdV9RdVViM1BCdW5HaTFMRkhzQ2xTMnJnR0NpMTRsdjlZUW5HX1FCSEtqVkdHRE8xOFNHb2JvNFloWkRjeGJNeWpHb0oxTkdEaXZXNUVsQnM?oc=5\" target=\"_blank\">Amgen upgraded to buy at UBS on potential of MariTide, olpasiran</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2026-01-06T22:09:38+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Cancer biotech Disco lines up Amgen as first pharma partner - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNbjdCQ2lFQlFfU2lhV19RNXIzSmtjZU9KWDZGVW9rSUp5cVpuN05nRUsycTVYd0piZ29neDIxYVh3aEFzU190T0tHMUJCb2Ywc1prV25yWlhINzV1THR6cE1aWHYwanc3UXlCX2ZvLTQ4YkRwSVRydVljS1UxMGpRbFBLNFFEV1haZG0w?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNbjdCQ2lFQlFfU2lhV19RNXIzSmtjZU9KWDZGVW9rSUp5cVpuN05nRUsycTVYd0piZ29neDIxYVh3aEFzU190T0tHMUJCb2Ywc1prV25yWlhINzV1THR6cE1aWHYwanc3UXlCX2ZvLTQ4YkRwSVRydVljS1UxMGpRbFBLNFFEV1haZG0w?oc=5\" target=\"_blank\">Cancer biotech Disco lines up Amgen as first pharma partner</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2026-01-07T10:00:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more - CNBC",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOYk1PMldaVWFrMU1tQWx3R1V1c0QzVVh1RlF0N21yREhFQlpJZG52dGZMS2trd1FsX1RxRlZfLTlNVTRRaWRGU3lkbnVNZ3VfRjZDT3k1YlhJb2tIQ25FaXFrQlg1S1dwSHRnQzZvZGhPeFdyaEJ3OHVMU2JrZ1J4U0FncXlsYkxQMTV5T0drQzZrcDg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxOYk1PMldaVWFrMU1tQWx3R1V1c0QzVVh1RlF0N21yREhFQlpJZG52dGZMS2trd1FsX1RxRlZfLTlNVTRRaWRGU3lkbnVNZ3VfRjZDT3k1YlhJb2tIQ25FaXFrQlg1S1dwSHRnQzZvZGhPeFdyaEJ3OHVMU2JrZ1J4U0FncXlsYkxQMTV5T0drQzZrcDg?oc=5\" target=\"_blank\">Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2026-01-07T17:20:08+00:00",
      "source": "CNBC"
    },
    {
      "title": "Amgen agrees to lower prescription drug costs in deal with US government - PMLiVE",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPdmV6V3ZsMmhJc1ZTM2VZSm8xNUUyUHdWVlZsSGE0MXdNajBfeng5ZlNYdnN3aEZvdHJRUVhINldzTlZtUlRCTXNQRTE2TVlnWDVReHpKVGltYjZHLXBSRVZzejlZN0tpWE55NFhiam0yQk5YVkFEeW1SWGlaM05TYTRUdTNMd1JLRlByQ2VnMkYtellZNVdVa240QTM5Mkx2VGlrTEp6RQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxPdmV6V3ZsMmhJc1ZTM2VZSm8xNUUyUHdWVlZsSGE0MXdNajBfeng5ZlNYdnN3aEZvdHJRUVhINldzTlZtUlRCTXNQRTE2TVlnWDVReHpKVGltYjZHLXBSRVZzejlZN0tpWE55NFhiam0yQk5YVkFEeW1SWGlaM05TYTRUdTNMd1JLRlByQ2VnMkYtellZNVdVa240QTM5Mkx2VGlrTEp6RQ?oc=5\" target=\"_blank\">Amgen agrees to lower prescription drug costs in deal with US government</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PMLiVE</font>",
      "published": "2026-01-07T12:52:11+00:00",
      "source": "PMLiVE"
    },
    {
      "title": "Amgen Sees IBD RS Rating Rise To 73 - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQUEYwNXBNd2NVNTVCUlFMSk1pamJBSUZBYTY3Q2dyXzZVcFlyaE4zdlVjQndrMExFZjkzNVRFN0Jsa2Jlcnh1UmFqRW5oU0R4QlF4Z29QQXVUdG8xenBoSlQwX19OOXNRampaVlgzRWE2WG1BQnQ0SVVIZ1lodHViY0d3UFRMdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxQUEYwNXBNd2NVNTVCUlFMSk1pamJBSUZBYTY3Q2dyXzZVcFlyaE4zdlVjQndrMExFZjkzNVRFN0Jsa2Jlcnh1UmFqRW5oU0R4QlF4Z29QQXVUdG8xenBoSlQwX19OOXNRampaVlgzRWE2WG1BQnQ0SVVIZ1lodHViY0d3UFRMdw?oc=5\" target=\"_blank\">Amgen Sees IBD RS Rating Rise To 73</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2026-01-07T08:00:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Pharmalittle: We’re reading about an Eli Lilly deal, an Amgen acquisition, and much more - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQMXNkdGY4RGZleFdXcDJRVEZtZlhXdERCRmZYNDNCdFVRSDJlU25XS2VoVEZGbHpISWU1Uy1fT1V1WEUtM09jdXBleXFXZTlSNHo1akNObkhZTWF4Vm5uTWIwTXhVTFBEeWdnS196SjR1QTBfcWYyMjVtLWxjS3ZkRVlNYnNlRWhneHJEd2tXZW0wblk2SWZNeU1RSUwwR24zT1B0RkhR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxQMXNkdGY4RGZleFdXcDJRVEZtZlhXdERCRmZYNDNCdFVRSDJlU25XS2VoVEZGbHpISWU1Uy1fT1V1WEUtM09jdXBleXFXZTlSNHo1akNObkhZTWF4Vm5uTWIwTXhVTFBEeWdnS196SjR1QTBfcWYyMjVtLWxjS3ZkRVlNYnNlRWhneHJEd2tXZW0wblk2SWZNeU1RSUwwR24zT1B0RkhR?oc=5\" target=\"_blank\">Pharmalittle: We’re reading about an Eli Lilly deal, an Amgen acquisition, and much more</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2026-01-07T14:36:48+00:00",
      "source": "statnews.com"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-07",
      "close": 341.6400146484375
    },
    "history": [
      {
        "date": "2025-12-29",
        "close": 329.6300048828125
      },
      {
        "date": "2025-12-30",
        "close": 328.69000244140625
      },
      {
        "date": "2025-12-31",
        "close": 327.30999755859375
      },
      {
        "date": "2026-01-02",
        "close": 327.6400146484375
      },
      {
        "date": "2026-01-05",
        "close": 320.7200012207031
      },
      {
        "date": "2026-01-06",
        "close": 330.1700134277344
      },
      {
        "date": "2026-01-07",
        "close": 341.6400146484375
      }
    ],
    "name": "Amgen Inc."
  }
}